Clinical Trials on No-Show Patients in Germany
Total 274 results
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompletedHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, France, Germany, Canada, Spain, United Kingdom, Mexico, Italy, Argentina, Chile, South Africa, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusSpain, France, Germany, United States, Italy, Romania, Russian Federation, Switzerland, Puerto Rico
-
ViiV HealthcareActive, not recruitingHIV Infections | HIVNetherlands, Germany, Mexico, Spain, United States, Belgium, Portugal, Canada, United Kingdom, Italy, Austria, France
-
ViiV HealthcareTerminatedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, France, Canada, Germany, Italy, Belgium, United Kingdom, Portugal, Spain
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV-1 Infection | Infection, Human Immunodeficiency Virus IGermany, Spain, France, Belgium, United Kingdom, Italy, Romania, Russian Federation, Switzerland
-
AbbottCompletedHuman Immunodeficiency Virus InfectionsUnited States, Australia, Belgium, Canada, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency Virus IGermany, Belgium, United Kingdom, Spain, Ireland, Italy, France, Austria, Denmark, Netherlands, Switzerland, Portugal, Latvia
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus - Type 1United States, France, United Kingdom, Germany, Taiwan, Spain, Argentina, Chile, Malaysia, Panama, Romania, South Africa, Thailand, Brazil, Puerto Rico, Austria, Hungary, Australia, Guatemala
-
Janssen R&D IrelandCompletedHepatitis C Virus Genotype-1United States, France, United Kingdom, Germany, Spain, Portugal, Canada, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IGermany, Spain, France, Australia, United States, Canada, United Kingdom, Italy, Russian Federation
-
ViiV HealthcareCompletedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Canada, Belgium, Portugal, Italy, France, United Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusFrance, Germany, United States, Canada, Belgium, Austria, Brazil, Italy, Poland
-
ViiV HealthcarePfizerCompletedHuman Immunodeficiency VirusUnited States, Canada, Spain, Belgium, France, United Kingdom, Italy, Brazil, Puerto Rico, Germany, Greece
-
ViiV HealthcareTerminatedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Germany, France, Canada, Spain, Italy, Portugal, United Kingdom, Denmark, Netherlands
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States, Belgium, France, Germany, Spain, Canada, Italy, Portugal, Romania, Austria, Switzerland, Poland, Latvia, Luxembourg
-
AbbVieRecruitingHuman Immuno-deficiency Virus (HIV) DiseaseUnited States, Puerto Rico, Japan, Spain, Germany, Canada, Belgium, France, Poland, South Africa, Italy
-
ViiV HealthcareTerminatedHIV-1 Infection | Infection, Human Immunodeficiency Virus IUnited States, France, Germany, Canada, Italy, Australia, Belgium, Portugal, Puerto Rico, Romania, United Kingdom
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Australia, Canada, Belgium, Denmark, Netherlands, United Kingdom, France, Italy, Romania
-
University of MinnesotaNational Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaboratorsCompletedHIV InfectionSpain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Argentina, Spain, Germany, Belgium, Australia, Canada, United Kingdom, Italy, Romania, Taiwan, Russian Federation, Mexico, France, Switzerland, Peru, Poland, Portugal
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedHIV Infections | Infection, Human Immunodeficiency VirusTaiwan, France, Germany, Belgium, United States, Canada, Netherlands, Spain, Korea, Republic of, Italy, Australia, United Kingdom, Russian Federation, Portugal, Argentina, South Africa, Romania, Mexico
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsActive, not recruitingHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada, Australia, Korea, Republic of, Italy, South Africa, Russian Federation, Argentina, Mexico, Sweden
-
NantCell, Inc.TakedaTerminatedCancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine CancerItaly, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more